BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26588464)

  • 1. The Chromatin Regulator CHD8 Is a Context-Dependent Mediator of Cell Survival in Murine Hematopoietic Malignancies.
    Shingleton JR; Hemann MT
    PLoS One; 2015; 10(11):e0143275. PubMed ID: 26588464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
    Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
    Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The signaling axis atypical protein kinase C λ/ι-Satb2 mediates leukemic transformation of B-cell progenitors.
    Nayak RC; Hegde S; Althoff MJ; Wellendorf AM; Mohmoud F; Perentesis J; Reina-Campos M; Reynaud D; Zheng Y; Diaz-Meco MT; Moscat J; Cancelas JA
    Nat Commun; 2019 Jan; 10(1):46. PubMed ID: 30610188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells.
    Manlove LS; Berquam-Vrieze KE; Pauken KE; Williams RT; Jenkins MK; Farrar MA
    J Immunol; 2015 Oct; 195(8):4028-37. PubMed ID: 26378075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
    Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
    Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
    Williams RT; Sherr CJ
    Adv Exp Med Biol; 2007; 604():107-14. PubMed ID: 17695724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.
    Kim JH; Penson AV; Taylor BS; Petrini JHJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15178-15183. PubMed ID: 31285322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemopoietic transformation by the TEL/ABL oncogene.
    Hannemann JR; McManus DM; Kabarowski JH; Wiedemann LM
    Br J Haematol; 1998 Jul; 102(2):475-85. PubMed ID: 9695962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chromatin remodeler CHD8 governs hematopoietic stem/progenitor survival by regulating ATM-mediated P53 protein stability.
    Tu Z; Wang C; Davis AK; Hu M; Zhao C; Xin M; Lu QR; Zheng Y
    Blood; 2021 Jul; 138(3):221-233. PubMed ID: 34292326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosin-IIA regulates leukemia engraftment and brain infiltration in a mouse model of acute lymphoblastic leukemia.
    Wigton EJ; Thompson SB; Long RA; Jacobelli J
    J Leukoc Biol; 2016 Jul; 100(1):143-53. PubMed ID: 26792819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
    Kukoc-Zivojnov N; Puccetti E; Chow KU; Bergmann M; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Boehrer S
    Exp Hematol; 2004 Jul; 32(7):649-56. PubMed ID: 15246161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
    Castor A; Nilsson L; Astrand-Grundström I; Buitenhuis M; Ramirez C; Anderson K; Strömbeck B; Garwicz S; Békássy AN; Schmiegelow K; Lausen B; Hokland P; Lehmann S; Juliusson G; Johansson B; Jacobsen SE
    Nat Med; 2005 Jun; 11(6):630-7. PubMed ID: 15908956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia.
    Mu Q; Wang Y; Chen B; Qian W; Meng H; Tong H; Chen F; Ma Q; Ni W; Chen S; Jin J
    Leuk Res; 2013 Aug; 37(8):922-7. PubMed ID: 23759245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the CDR3 structure of the Vβ21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia.
    Zha X; Chen S; Yang L; Li B; Chen Y; Yan X; Li Y
    Hum Immunol; 2011 Oct; 72(10):798-804. PubMed ID: 21820025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved and Distinct Functions of the Autism-Related Chromatin Remodeler CHD8 in Embryonic and Adult Forebrain Neurogenesis.
    Dong C; Zhao C; Chen X; Berry K; Wang J; Zhang F; Liao Y; Han R; Ogurek S; Xu L; Zhang L; Lin Y; Zhou W; Xin M; Lim DA; Campbell K; Nakafuku M; Waclaw RR; Lu QR
    J Neurosci; 2022 Nov; 42(44):8373-8392. PubMed ID: 36127134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector.
    Uchida N; Hanawa H; Dan K; Inokuchi K; Shimada T
    J Nippon Med Sch; 2009 Jun; 76(3):134-47. PubMed ID: 19602820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.
    Reuther JY; Reuther GW; Cortez D; Pendergast AM; Baldwin AS
    Genes Dev; 1998 Apr; 12(7):968-81. PubMed ID: 9531535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHP2 is required for BCR-ABL1-induced hematologic neoplasia.
    Gu S; Sayad A; Chan G; Yang W; Lu Z; Virtanen C; Van Etten RA; Neel BG
    Leukemia; 2018 Jan; 32(1):203-213. PubMed ID: 28804122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model mice for BCR/ABL-positive leukemias.
    Honda H; Hirai H
    Blood Cells Mol Dis; 2001; 27(1):265-78. PubMed ID: 11358387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.